Martina Flammer - May 11, 2022 Form 4 Insider Report for INSMED Inc (INSM)

Role: Chief Medical Officer
Signature: /s/ Martina Flammer, M.D., by Michael Smith as Attorney in Fact
Stock symbol: INSM
Transactions as of: May 11, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/13/2022, 06:11 PM
Previous filing: Jan 13, 2022
Next filing: May 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSM	Common Stock	Award		+22K	+47.72%		68K	May 11, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INSM	Stock Option (right to buy)	Award	$0	+104K		$0.00	104K	May 11, 2022	Common Stock	104K	$17.07	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.
F2	Each Restricted Stock Unit was received as a grant on May 11, 2022, for no consideration.
F3	Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.